287 related articles for article (PubMed ID: 36600993)
1. Neuronal oscillations: early biomarkers of psychiatric disease?
Günther A; Hanganu-Opatz IL
Front Behav Neurosci; 2022; 16():1038981. PubMed ID: 36600993
[TBL] [Abstract][Full Text] [Related]
2. Magnetoencephalography as a Tool in Psychiatric Research: Current Status and Perspective.
Uhlhaas PJ; Liddle P; Linden DEJ; Nobre AC; Singh KD; Gross J
Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Apr; 2(3):235-244. PubMed ID: 28424797
[TBL] [Abstract][Full Text] [Related]
3. Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders.
Penzes P; Buonanno A; Passafaro M; Sala C; Sweet RA
J Neurochem; 2013 Jul; 126(2):165-82. PubMed ID: 23574039
[TBL] [Abstract][Full Text] [Related]
4. Human iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development.
Heider J; Vogel S; Volkmer H; Breitmeyer R
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638595
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders.
Morella IM; Brambilla R; Morè L
Neurosci Biobehav Rev; 2022 Nov; 142():104892. PubMed ID: 36181925
[TBL] [Abstract][Full Text] [Related]
6. Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies.
Eltokhi A; Santuy A; Merchan-Perez A; Sprengel R
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374598
[TBL] [Abstract][Full Text] [Related]
7. Neurobiological perspective of 22q11.2 deletion syndrome.
Zinkstok JR; Boot E; Bassett AS; Hiroi N; Butcher NJ; Vingerhoets C; Vorstman JAS; van Amelsvoort TAMJ
Lancet Psychiatry; 2019 Nov; 6(11):951-960. PubMed ID: 31395526
[TBL] [Abstract][Full Text] [Related]
8. Neuronal dynamics and neuropsychiatric disorders: toward a translational paradigm for dysfunctional large-scale networks.
Uhlhaas PJ; Singer W
Neuron; 2012 Sep; 75(6):963-80. PubMed ID: 22998866
[TBL] [Abstract][Full Text] [Related]
9. [Epigenetics' implication in autism spectrum disorders: A review].
Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
[TBL] [Abstract][Full Text] [Related]
10. Developmental timing and critical windows for the treatment of psychiatric disorders.
Marín O
Nat Med; 2016 Nov; 22(11):1229-1238. PubMed ID: 27783067
[TBL] [Abstract][Full Text] [Related]
11. A Review of Default Mode Network Connectivity and Its Association With Social Cognition in Adolescents With Autism Spectrum Disorder and Early-Onset Psychosis.
Nair A; Jolliffe M; Lograsso YSS; Bearden CE
Front Psychiatry; 2020; 11():614. PubMed ID: 32670121
[TBL] [Abstract][Full Text] [Related]
12. Prefrontal Cortex Development in Health and Disease: Lessons from Rodents and Humans.
Chini M; Hanganu-Opatz IL
Trends Neurosci; 2021 Mar; 44(3):227-240. PubMed ID: 33246578
[TBL] [Abstract][Full Text] [Related]
13. Reelin and Neuropsychiatric Disorders.
Ishii K; Kubo KI; Nakajima K
Front Cell Neurosci; 2016; 10():229. PubMed ID: 27803648
[TBL] [Abstract][Full Text] [Related]
14. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of GABAergic Signaling in Neurodevelomental Disorders: Targeting Cation-Chloride Co-transporters to Re-establish a Proper E/I Balance.
Cherubini E; Di Cristo G; Avoli M
Front Cell Neurosci; 2021; 15():813441. PubMed ID: 35069119
[TBL] [Abstract][Full Text] [Related]
16. A neurophysiological insight into the potential link between transcranial magnetic stimulation, thalamocortical dysrhythmia and neuropsychiatric disorders.
Fuggetta G; Noh NA
Exp Neurol; 2013 Jul; 245():87-95. PubMed ID: 23063603
[TBL] [Abstract][Full Text] [Related]
17. The potential of biomarkers in psychiatry: focus on proteomics.
Sokolowska I; Ngounou Wetie AG; Wormwood K; Thome J; Darie CC; Woods AG
J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S9-18. PubMed ID: 24357051
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.
Moos WH; Maneta E; Pinkert CA; Irwin MH; Hoffman ME; Faller DV; Steliou K
Drug Dev Res; 2016 Mar; 77(2):53-72. PubMed ID: 26899191
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia.
Quintero M; Stanisic D; Cruz G; Pontes JGM; Costa TBBC; Tasic L
Adv Exp Med Biol; 2019; 1118():271-293. PubMed ID: 30747428
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
